---All---
  • ---All---
  • Accession
  • Catalog #

PRKAR2A Antibody (monoclonal) (M01)Purified Mouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AT3430a 100 ug 400 ul 7-10 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

PRKAR2A Antibody (monoclonal) (M01) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP13861
ReactivityHuman
IsotypeIgG1 Kappa
Clone Names6A9
Calculated MW45518 Da

PRKAR2A Antibody (monoclonal) (M01) - Additional info

Gene ID 5576
Other Names
MGC3606, PKR2, PRKAR2protein kinase, cAMP-dependent, regulatory, type II, alpha
Target/Specificity
PRKAR2A (AAH02763, 1 a.a. ~ 105 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Dilution
WB~~1:500~1000
Format
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
PRKAR2A Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.

PRKAR2A Antibody (monoclonal) (M01) - Related products

AP6823a: PRKAR2A Antibody (N-term)

AP6823c: PRKAR2A Antibody (Center)

AP8096a: PKA R2 (PKR2) Antibody (N-term)

RI14218: PRKAR2A predesign siRNA

DC01098: Human PRKAR2A cDNA Clone

LY10107a: PRKAR2A Over-expression Lysate

BP6823a: PRKAR2A Antibody (N-term) Blocking Peptide

BP6823c: PRKAR2A Antibody (Center) Blocking Peptide

BP8096a: PKR2 Antibody (N-term) Blocking Peptide

AT3430a: PRKAR2A Antibody (monoclonal) (M01)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. It may interact with various A-kinase anchoring proteins and determine the subcellular localization of cAMP-dependent protein kinase. This subunit has been shown to regulate protein transport from endosomes to the Golgi apparatus and further to the endoplasmic reticulum (ER).

REFERENCES

Biological Pathway-Based Genome-Wide Association Analysis Identified the Vasoactive Intestinal Peptide (VIP) Pathway Important for Obesity. Liu YJ, et al. Obesity (Silver Spring), 2010 Apr 8. PMID 20379146.Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. So HC, et al. Am J Med Genet B Neuropsychiatr Genet, 2010 Jan 5. PMID 19367581.Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways. Yeager LA, et al. Infect Immun, 2009 Jun. PMID 19307216.Isoform-specific PKA dynamics revealed by dye-triggered aggregation and DAKAP1alpha-mediated localization in living cells. Martin BR, et al. Chem Biol, 2007 Sep. PMID 17884635.Anchoring of protein kinase A-regulatory subunit IIalpha to subapically positioned centrosomes mediates apical bile canalicular lumen development in response to oncostatin M but not cAMP. Wojtal KA, et al. Mol Biol Cell, 2007 Jul. PMID 17494870.